CA2392544A1 - Natural therapeutic composition for the treatment of wounds and sores - Google Patents
Natural therapeutic composition for the treatment of wounds and sores Download PDFInfo
- Publication number
- CA2392544A1 CA2392544A1 CA002392544A CA2392544A CA2392544A1 CA 2392544 A1 CA2392544 A1 CA 2392544A1 CA 002392544 A CA002392544 A CA 002392544A CA 2392544 A CA2392544 A CA 2392544A CA 2392544 A1 CA2392544 A1 CA 2392544A1
- Authority
- CA
- Canada
- Prior art keywords
- vitamin
- oil
- composition
- sores
- mineral oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Abstract
A therapeutic composition comprised of natural ingredients, namely quantities of Vitamin A, Vitamin E, Evening Primrose Oil and Mineral Oil, utilized with or without a suitable carrier, to safely and effectively soothe inflammation, ease pain, and promote the natural healing process of wounds and sores, particularly bed sores and in the treatment of diseases, particularly psoriasis and ezcema.
More specifically, the Invention, in one of its preferred embodiments, is a composition comprised of a combination of Vitamin A, Vitamin E, Evening Primrose Oil and Mineral Oil in specific quantities, to be applied topically or orally, particularly to bed sores, to reduce inflammation, ease pain, and assist the healing process of such wounds, sores and diseases. A
quantity of Vitamin C and other natural ingredients may also be added to the composition with complimentary effects and with or without a carrier such as Petroleum Jelly in topical applications.
More specifically, the Invention, in one of its preferred embodiments, is a composition comprised of a combination of Vitamin A, Vitamin E, Evening Primrose Oil and Mineral Oil in specific quantities, to be applied topically or orally, particularly to bed sores, to reduce inflammation, ease pain, and assist the healing process of such wounds, sores and diseases. A
quantity of Vitamin C and other natural ingredients may also be added to the composition with complimentary effects and with or without a carrier such as Petroleum Jelly in topical applications.
Description
11TLE: Natural therapeutic composition for the treatrnent of wounds and sores This invention relates to a therapeutic composition for the treatment of wounds, sores, and diseases.
Studies have shown that Vitamin A plays a role in the maintenance of skin;
that Vitamin C
helps fight infections, promotes the healing of cuts, abrasions and "rounds and is required to maintain structural and functional integrity of cell walls and small blood vessels; that Vitamin E helps prevent oxidation of fatty acids present in the membrane of all cells;
that Evening Primrose oil has anti-inflammatory and pain relieving effects; that mineral oil may be used to cleanse the skin; and that petroleum belly may be used as a carrier for topical comp~itions.
The prior art relevant to this invention consists of various wound healing and anti-inflammatory compositions comprised of one or a few of the above ingredients and other herbal, vitamin and chemical mixtures.
It is laiown in the art that skin wound healing may be enhanced by the topical application of vitamin, herbal and/or chemical compositions to the affected area or through the ingestion of some such compositions. However, existing inventions inadequately address the need for a therapeutic composition that is all natural, provides fast pain relief, reduces inflammation arid enhances the healing of wownds and sores.
United States Patent No. 4,505,896 bo J. E. Bernstein, filed Navtmber 24, 1980, is a topical and oral method of treating lesions of acne vulgaris. It is comprised of a therapeutically effective amount of nicotine acid or nicotinannide. (The Bernstein patent does not claim use of Vitamin A, Vitamin C, Vitamin E, Evening Primrose oil, mineral oil nor a petroleum carrier).
United States Patent No. 5,176,918 to J. L. )ones, filed December 20, 1990, is a topical medicament, comprised of a dilute solution of sodium bicarbonate and a transdermal carrier for relieving pain from sunburn; minor burns and minor inflammatory diseases. (The Jones patent uses a transdetTnal carrier, typically glycerin, but does not claim uiae of Vitamin A, Vitamin C, Vitamin E, Evening Primrose oil nor mineral oil).
United States Patent No. 5,240,945 to T. G. Warshaw, filed February 18, 1992, is a method arid composition for treating acne comprised of a lower alkyl nicotinate or methyl rucotinate. (The Warshaw patent utilizes a topically acceptable and compatible pharmaceutical carrier, such as petrolatum, but does not claim use of Vitamin A, Vitamin C, Vitamin E, Evening Primrose oil nor mineral oil).
United States Patent No. 3,96b,452 to B. A. Whittle, filed February 28, 1992, is a pharmaceutical composition for the treatment of skin disorders comprised of extracts of herbs to provide an anti-inflammatory agent, an adrenocortical stimulant and a cortisol protectnng agent. The herbs may be chosen hum a group consist;ng of Potentilla chittensis, Tribulus terrestris, Akebia trifoliate and select others. The solvent may be chosen from a group consisting of chloroform, methylene chloride, acetone, propanol, ethanol, methanol and select others. (The Whittle patent claims use of a carrier in form of a silica gel, but does not claim use of Vitamin A, Vitamin C, Vitamin EP Evening Primrose oil nor mineral oil).
"Early Clinical Experience with Topical Collagen in Vascular Wa~.wd Care", by J. Morris et al, published in 1994 by the Wound, Ostomy and Continetxe Nurses Society, discusses waa~d treatment for bilateral venous ulcers, including topical application of soap and water, hydrogen peroxide, saline solution and collagen. (The treatment mentioned in the article does not claim use of Vitamin A, Vitamin C, Vitamin E, Evening Primrose oil, mineral oil na a petroleum carrier).
Canadian Patent No. 2,191,604 (United States Patent no. 5,648,380) to A.
Martin, filed May 22, 1995, laid open January 11, 1996, is a therapeutic anti-inflammatory wwnd healing composition comprised of an anti-inflammatory agent and a wound healing composition. The wound healing composition is comprised of pyruvate, an antioxidant and a mixture of saturated and unsaturated fatty acids. The anti-inflammatory agent may be chosen from a ge~oup consisting of etodale, evening primrose oil, salsalate, cortisone, and select others. The antioxidant may be chosen from a group conaiatirAg of all forms of Vitamin A, Vitamin C, Vitamin E and mixtures thereof. The composition is also earnprised of a pharmaceutically acceptable carrier. This may be distinguished from this invention by mineral oil in the claims.
Canadian Patent No. 2.192,603 (United States Patent No. 5,663,208} to A.
Martin, filed May 22, 1995, laid open February 8,1996, is an anti-fungal wound healing composition with anti-fungal agent comprised of lactic and sorbic acid, terconazole or select others.
United States Patent No. 5,652,274 to A. Martin, filed May 22, 1995, is a therapeutic wound healing composition and method of preparation. The wood healing composition is comprised of pryuvate, an antioxidant and a mixture of saturated and unsaturated fatty acids. This may be distinguished from this invention by mineral oil in the claims.
United States Patent No. 5,674,912 to A. Martin, filed May 22, 1995, is a sun-screen wau~d healing composition and method of preparation. The sumcseen agent may be selected from a group consisting of titanium dioxide, urea, oxybenzone and select others.
(All the Martin patents claim use of Vitamin A, Vitamin C, and/or Vitamin E as an antioxidant, Evening Primrose oil as an anti-inflammatory agent and a pharmaceutically acceptable carrier. However, the Martin patents require that an agent and a wound healing rnmposition, that must be comprised of pyruvate, an antioxidant, and a mixture of saturated and unsaturated fatty acids, must be used together. The Martin patents do not claim v,~se of mineral oil). ' United States Patent No. 5,916,573 to S. M. Spiers et al, filed August 1996, is a topical treatment of the skin with, a grape-seed oil comp~ition. The composition is comprised of grape-seed oil, a hydrating agent that may be chosen from a group rnnsisting of Vitamin E oil, primrose oil and select others, an amino acid and deionized water. (The Spiers patent does not claim use of Vitamin A, Vitamin C, nor mineral oil).
United States Patent No. 6,107,349 to P. Mantynen, filed April 16, 1998, is a method and composition for treating psoriasis. The method is rnmprised of oral ingestion by a patient of Vitamin E, Evening Primrose oil, folic acid and B-complex vitamins. (The Mantynen patent is not topical and does not claim use of Vitamin A, Vitamin C, mineral oil nor a petroleum carrier).
Canadian Patent No. 2,329,160 to S. Leibovich (United States patent no.
6,187,822), filed in the United State on June 11, 1998, laid open in Canada on De~nber 16, 1999, is a wound treatment through inhibition of adenosine diphosphate ribosyl transferase. The inhibitor is comprised from a group consisti~ of Vitamin K1, KZ, K3, K4 and select others. The rnmposition is further comprised of a pharmaceutically acceptable carrier. An anti-inflammatory agent may also be used that is comprised of Evening Primrose oil. (The Leibovich patent does not claim use of Vitamin A, Vitamin~C, Vitamin E nor mineral oil).
United Stated Patent No. 6,203,805 to D. F. Collies et al, filed November 10, 1998, is a topical composition containing whey proteins, Vitamin A, Vitamin C and Vitamin E to improve the resiliency of the skin. (The Collies patent does not claim use of Evening Primrose oil, mineral oil nor a petroleum carrier).
German Patent No.19800982 to F. Karl-Heinz, filed January 14, 1999, is an ointment containing ethereal oil, liposomes and Vitamins for treating neruodermatitis, psoriasis and eczema. The medical ointment base is comprised of ingredients selected from a group comprised of Vaseline, beeswax, paraffin or select others. The active ingredient used in conjunction with the base may be chosen from a group consisting of vitamins, lfposome and ethereal. (The Karl-Heinz patent does not claim use of Evening Primrose oil nor mineral oil).
United Stated Patent No. 6,183,761 to D. L. Bissett, filed March 12, 1999, is a composition for regulating skin appearance. The topical composition is comprised of a vitamin B3 compound, a polycyclic compound, flavanones, chalcones, isoflavones, coumarins, chromones, dicomarols, chromaeols, sterols, selected others and mixtures thereof. (The Bissett patent does not claim use of Vitamin A, Vitamin C, Vitamin E, Evening Primrose oil, mineral oil nor a petroleum carrier).
Canadian Patent No. 2,285,818 to J. C. Liu et al, filed October 12,1999, laid open April 13, 2000, is a composition to enhance skin permeation of topical skin agents. The composition l s comprised of an active agent that may be chosen from a grcnip consisting of hydrophobic and hydrophilic active agents and a polymeric emu),sifier. The hydrophobic and hydrophilic agents may be f~nm a group c~sisting~of ~Vftamin A, Vitamin C, Vitamin E, wound healing promoters, sunscreens, fragrances, and select others. (The Liu patent does not claim use of Evening Primrose oil, mineral oil nor a petroleum~carrier).
United States Patent No. 6,248,763 to R Scivoletto, filed October 12,1999, is a rnmposition for treating skin conditions, comprising of methyl nicotinate, aloe vera gel, Vitamin E, glycerin, silk amino acids and select others. (The liernstein patent does rat claim use of Vitamin A, Vitamin C, Evening Primrose oil,, nor mineral oil).
United States Patent No. 6,187,743 to E. T. Obi-Tabot, filed December 10, 1999, is a composition and method for enhancing wound healing. The method is comprised of a composition of bovine collagen type I and aipha-tocopherol in a mixture which may be combined with vitamins.
('The Obi-Tabot patent does not claim t~se of Evening Primrose oil, mineral oil nor a petroleum carrier).
As disclosed above, a number of wound and disease treating compositions exist that are topical and ingested, and are composed of herbs, chemicals, and vitamins. However, none of the prior art discloses an invention that utilizes a topically and orally administered natural therapeutic composition for the treatment of diseases and wounds comprised of a mixture of Vitamin A, Vitamin E, Evening Primrose Oil and Mineral Oil.
Summary of the invention This invention relates to a therapeutic composition for the treatment of wounds and diseases that is comprised of natural ingredients.
From personal experience we have discovered the following traits associated with the specific components of the invention:
Vitamin A topically applied to the skin, particularly on the face, results in improved appearance of the skin;
Vitamin C acts like natural Aspiring by combating pain and inflammation. It is known to help arthritis;
Vitamin E topically applied to scalds results in reduced pain and improved healing of the wound;
Evenin;~ Primrose Oil topically applied to the face results in a healthier appearance of the skin. Used on wounds, i.e. after a gall bladder surgery, applied daily for six weeks, results in advanced healing of the wound. It may also be used to treat chronic fatigue syndrome;
Mineral Oil topically applied to severe sunburn may result in easement of pain and reduced inflammation of the wound;
Mynah has antiseptic and astringent properties that may reduce inflammation and infection, thereby promoting healing of healthy tissue;
Olive Oil aids in dry skin problems and helps to clean and heal wounds, ulcers, sores, abrasions, and sunburn; and, Peppermint Extract topically applied, particularly to the head, results in reduced pain in, for example, cases of headache, sinus and earache.
Using our knowledge of and experience with the above ingredients, we experimented with various quantities of all of the ingredients combined into one composition, with several slight variants for specific indications. We discovered that the ingredients work well together and complemented and enhanced the restorative and healing effects of each other when combined, particularly in the proportions disclosed in the formulae of the various embodiments of the invention.
The invention is comprised of four (4) main elements and may be used topically or internally:
(a) Vitamin A
(b) Vitamin E
(c) Evening Primrose Oil (d) Mineral Oil In addition to the elements listed above, small amounts of Vitamin C and other natural ingredients such as Olive Oil, Peppermint Extract and Myrrah may be present in some embodiments. Additionally, some embodiments may use a suitable Garner, such as Petroleum Jelly, for topical application. The amount of carrier used can be varied to regulate the consistency of the composition. In some indications a thicker composition is more desirable.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
The invention, in a first preferred embodiment, is a topical or oral composition comprised of the following ingredients in the :Following proportions by volumes:
Vitamin A 0.5 - 2.5 Vitamin E 35 - 45 Evening Primrose Oil 45 - 55 Mineral Oil 4.5 - 6.5 This embodiment of the invention is effective as a therapeutic agent for the treatment of bedsores, earache, headache, and ezcema of and around the eye when applied on or proximal to the affected areas.
Example : A test of the preferred embodiment of the invention was performed in February 2001 using the following composition of ingredients:
Vitamin A 0.5 ml Vitamin E 15 ml Evening Primrose 20 ml Oil Mineral Oil 2.0 ml The patient was suffering from severe bedsores. We topically applied the composition of the preferred embodiment of the invention to the patient's wounds daily with startling success. The attending physicians and care workers were also very impressed with the results. The patient admitted that th.e pain diminished instantly upon the application of the composition that is the preferred embodiment of this invention and after five days of daily use, the sores were not painful at all. The inflammation of the wound greatly diminished and the wound appeared to be healing from the inside to the outside, at a rate much more rapid than normally associated with such sores. We have also tried the invention on itches, scalds, cold sores, sore throats, and burns with similar results.
In a second and further embodiment, the present invention provides a topical composition comprised of the same proportions of ingredients as in the first embodiment above, but using Petroleum Jelly as a carrier.
We have used the second embodiment in the successful treatment of psoriasis, body itch, insect bites, burns and scalds, and dry skin on the hands and face when it was applied on or proximal to the affected areas.
In a third and further embodiment, the present invention provides a topical composition comprised of the following ingredients in the following proportions by volumes:
Vitamin A 0.5 - 2.0 Vitamin E 30 - 45 Evening Primrose 45 - 55 Oil Mineral Oil 4 6 -Olive Oil 4 6 -in a suitable as carrier, such Petroleum Jelly.
We have used the third embodiment in the successful treatment of psoriasis, body itch, insect bites, dry skin on the face and hands, burns and scalds by applying it on or proximal to the affected areas. In one example of the third embodiment used topically for such treatment the composition had the following ingredients:
Vitamin A 0.5 ml Vitamin E 15 ml Evening Primrose 20 ml Oil Mineral Oil 2.0 ml Olive Oil 2.0 rnl In a fourth and further embodiment, the present invention provides a topical composition comprised of the following ingredients in the following proportions by volumes:
Vitamin A 0.5 - 2 Vitamin C 2 3.5 -Vitamin E 30 - 40 Evening Primrose 45 - .SS
Oil Mineral Oil 3.5 - 6.5 Myrrah 0.5 - 1.5 Olive Oil 3.5 - 6.5 in a suitable carrier, such as Petroleum Jelly.
We have used the fourth embodiment in the successful treatment of some types of psoriasis and some types of ezcema by applying it on or proximal to the affected area. In one example of the fourth embodiment used topically for such treatment the composition had the following ingredients:
Vitamin A 0.5 ml Vitamin C 1.0 ml Vitamin E 15 rr~l Evening Primrose 20 ml Oil Mineral Oil 2.0 ml Myrrah 0.4 rnl Olive Oil 2.0 ml In a fifth and further embodiment, the present invention provides a topical or oral composition comprised of the following ingredients in the following proportions by volumes:
Vitamin A 0.5 - 2 Vitamin C 2 - 3.5 Vitamin E 30 - 40 Evening Primrose 45 - 55 Oil Mineral Oil 3.5 - 6.5 Myrrah 0.5 - 1.5 Olive Oil 3.5 - b.5 Peppermint Extract0.5 - 1.5 in a suitable carrier, such as Petroleum Jelly, for topical applications.
We have used the fifth embodiment in the successful treatment of headaches and migraine. In one example of the fifth embodiment used topically by applying it on or proximal to the affected areas fox such treatment, the composition had the following ingredients:
Vitamin A 0.5 ml Vitamin C 1.0 ml Vitamin E 15 ml Evening Primrose 20 ml Oil Mineral Oil 2.0 ml Myrrah 0.4 ml Olive Oil 2.0 ml Peppermint Extract0.4 rnl As demonstrated, the invention provides a new and effective therapeutic composition comprised of all natural ingredients, for the treatment of wounds, sores and diseases.
While the invention has been described in detail and with reference to specific embodiments thereof, it will be apparent to one skilled in the art that various changes and modifications can be made therein without departing from the spirit and scope thereof.
Studies have shown that Vitamin A plays a role in the maintenance of skin;
that Vitamin C
helps fight infections, promotes the healing of cuts, abrasions and "rounds and is required to maintain structural and functional integrity of cell walls and small blood vessels; that Vitamin E helps prevent oxidation of fatty acids present in the membrane of all cells;
that Evening Primrose oil has anti-inflammatory and pain relieving effects; that mineral oil may be used to cleanse the skin; and that petroleum belly may be used as a carrier for topical comp~itions.
The prior art relevant to this invention consists of various wound healing and anti-inflammatory compositions comprised of one or a few of the above ingredients and other herbal, vitamin and chemical mixtures.
It is laiown in the art that skin wound healing may be enhanced by the topical application of vitamin, herbal and/or chemical compositions to the affected area or through the ingestion of some such compositions. However, existing inventions inadequately address the need for a therapeutic composition that is all natural, provides fast pain relief, reduces inflammation arid enhances the healing of wownds and sores.
United States Patent No. 4,505,896 bo J. E. Bernstein, filed Navtmber 24, 1980, is a topical and oral method of treating lesions of acne vulgaris. It is comprised of a therapeutically effective amount of nicotine acid or nicotinannide. (The Bernstein patent does not claim use of Vitamin A, Vitamin C, Vitamin E, Evening Primrose oil, mineral oil nor a petroleum carrier).
United States Patent No. 5,176,918 to J. L. )ones, filed December 20, 1990, is a topical medicament, comprised of a dilute solution of sodium bicarbonate and a transdermal carrier for relieving pain from sunburn; minor burns and minor inflammatory diseases. (The Jones patent uses a transdetTnal carrier, typically glycerin, but does not claim uiae of Vitamin A, Vitamin C, Vitamin E, Evening Primrose oil nor mineral oil).
United States Patent No. 5,240,945 to T. G. Warshaw, filed February 18, 1992, is a method arid composition for treating acne comprised of a lower alkyl nicotinate or methyl rucotinate. (The Warshaw patent utilizes a topically acceptable and compatible pharmaceutical carrier, such as petrolatum, but does not claim use of Vitamin A, Vitamin C, Vitamin E, Evening Primrose oil nor mineral oil).
United States Patent No. 3,96b,452 to B. A. Whittle, filed February 28, 1992, is a pharmaceutical composition for the treatment of skin disorders comprised of extracts of herbs to provide an anti-inflammatory agent, an adrenocortical stimulant and a cortisol protectnng agent. The herbs may be chosen hum a group consist;ng of Potentilla chittensis, Tribulus terrestris, Akebia trifoliate and select others. The solvent may be chosen from a group consisting of chloroform, methylene chloride, acetone, propanol, ethanol, methanol and select others. (The Whittle patent claims use of a carrier in form of a silica gel, but does not claim use of Vitamin A, Vitamin C, Vitamin EP Evening Primrose oil nor mineral oil).
"Early Clinical Experience with Topical Collagen in Vascular Wa~.wd Care", by J. Morris et al, published in 1994 by the Wound, Ostomy and Continetxe Nurses Society, discusses waa~d treatment for bilateral venous ulcers, including topical application of soap and water, hydrogen peroxide, saline solution and collagen. (The treatment mentioned in the article does not claim use of Vitamin A, Vitamin C, Vitamin E, Evening Primrose oil, mineral oil na a petroleum carrier).
Canadian Patent No. 2,191,604 (United States Patent no. 5,648,380) to A.
Martin, filed May 22, 1995, laid open January 11, 1996, is a therapeutic anti-inflammatory wwnd healing composition comprised of an anti-inflammatory agent and a wound healing composition. The wound healing composition is comprised of pyruvate, an antioxidant and a mixture of saturated and unsaturated fatty acids. The anti-inflammatory agent may be chosen from a ge~oup consisting of etodale, evening primrose oil, salsalate, cortisone, and select others. The antioxidant may be chosen from a group conaiatirAg of all forms of Vitamin A, Vitamin C, Vitamin E and mixtures thereof. The composition is also earnprised of a pharmaceutically acceptable carrier. This may be distinguished from this invention by mineral oil in the claims.
Canadian Patent No. 2.192,603 (United States Patent No. 5,663,208} to A.
Martin, filed May 22, 1995, laid open February 8,1996, is an anti-fungal wound healing composition with anti-fungal agent comprised of lactic and sorbic acid, terconazole or select others.
United States Patent No. 5,652,274 to A. Martin, filed May 22, 1995, is a therapeutic wound healing composition and method of preparation. The wood healing composition is comprised of pryuvate, an antioxidant and a mixture of saturated and unsaturated fatty acids. This may be distinguished from this invention by mineral oil in the claims.
United States Patent No. 5,674,912 to A. Martin, filed May 22, 1995, is a sun-screen wau~d healing composition and method of preparation. The sumcseen agent may be selected from a group consisting of titanium dioxide, urea, oxybenzone and select others.
(All the Martin patents claim use of Vitamin A, Vitamin C, and/or Vitamin E as an antioxidant, Evening Primrose oil as an anti-inflammatory agent and a pharmaceutically acceptable carrier. However, the Martin patents require that an agent and a wound healing rnmposition, that must be comprised of pyruvate, an antioxidant, and a mixture of saturated and unsaturated fatty acids, must be used together. The Martin patents do not claim v,~se of mineral oil). ' United States Patent No. 5,916,573 to S. M. Spiers et al, filed August 1996, is a topical treatment of the skin with, a grape-seed oil comp~ition. The composition is comprised of grape-seed oil, a hydrating agent that may be chosen from a group rnnsisting of Vitamin E oil, primrose oil and select others, an amino acid and deionized water. (The Spiers patent does not claim use of Vitamin A, Vitamin C, nor mineral oil).
United States Patent No. 6,107,349 to P. Mantynen, filed April 16, 1998, is a method and composition for treating psoriasis. The method is rnmprised of oral ingestion by a patient of Vitamin E, Evening Primrose oil, folic acid and B-complex vitamins. (The Mantynen patent is not topical and does not claim use of Vitamin A, Vitamin C, mineral oil nor a petroleum carrier).
Canadian Patent No. 2,329,160 to S. Leibovich (United States patent no.
6,187,822), filed in the United State on June 11, 1998, laid open in Canada on De~nber 16, 1999, is a wound treatment through inhibition of adenosine diphosphate ribosyl transferase. The inhibitor is comprised from a group consisti~ of Vitamin K1, KZ, K3, K4 and select others. The rnmposition is further comprised of a pharmaceutically acceptable carrier. An anti-inflammatory agent may also be used that is comprised of Evening Primrose oil. (The Leibovich patent does not claim use of Vitamin A, Vitamin~C, Vitamin E nor mineral oil).
United Stated Patent No. 6,203,805 to D. F. Collies et al, filed November 10, 1998, is a topical composition containing whey proteins, Vitamin A, Vitamin C and Vitamin E to improve the resiliency of the skin. (The Collies patent does not claim use of Evening Primrose oil, mineral oil nor a petroleum carrier).
German Patent No.19800982 to F. Karl-Heinz, filed January 14, 1999, is an ointment containing ethereal oil, liposomes and Vitamins for treating neruodermatitis, psoriasis and eczema. The medical ointment base is comprised of ingredients selected from a group comprised of Vaseline, beeswax, paraffin or select others. The active ingredient used in conjunction with the base may be chosen from a group consisting of vitamins, lfposome and ethereal. (The Karl-Heinz patent does not claim use of Evening Primrose oil nor mineral oil).
United Stated Patent No. 6,183,761 to D. L. Bissett, filed March 12, 1999, is a composition for regulating skin appearance. The topical composition is comprised of a vitamin B3 compound, a polycyclic compound, flavanones, chalcones, isoflavones, coumarins, chromones, dicomarols, chromaeols, sterols, selected others and mixtures thereof. (The Bissett patent does not claim use of Vitamin A, Vitamin C, Vitamin E, Evening Primrose oil, mineral oil nor a petroleum carrier).
Canadian Patent No. 2,285,818 to J. C. Liu et al, filed October 12,1999, laid open April 13, 2000, is a composition to enhance skin permeation of topical skin agents. The composition l s comprised of an active agent that may be chosen from a grcnip consisting of hydrophobic and hydrophilic active agents and a polymeric emu),sifier. The hydrophobic and hydrophilic agents may be f~nm a group c~sisting~of ~Vftamin A, Vitamin C, Vitamin E, wound healing promoters, sunscreens, fragrances, and select others. (The Liu patent does not claim use of Evening Primrose oil, mineral oil nor a petroleum~carrier).
United States Patent No. 6,248,763 to R Scivoletto, filed October 12,1999, is a rnmposition for treating skin conditions, comprising of methyl nicotinate, aloe vera gel, Vitamin E, glycerin, silk amino acids and select others. (The liernstein patent does rat claim use of Vitamin A, Vitamin C, Evening Primrose oil,, nor mineral oil).
United States Patent No. 6,187,743 to E. T. Obi-Tabot, filed December 10, 1999, is a composition and method for enhancing wound healing. The method is comprised of a composition of bovine collagen type I and aipha-tocopherol in a mixture which may be combined with vitamins.
('The Obi-Tabot patent does not claim t~se of Evening Primrose oil, mineral oil nor a petroleum carrier).
As disclosed above, a number of wound and disease treating compositions exist that are topical and ingested, and are composed of herbs, chemicals, and vitamins. However, none of the prior art discloses an invention that utilizes a topically and orally administered natural therapeutic composition for the treatment of diseases and wounds comprised of a mixture of Vitamin A, Vitamin E, Evening Primrose Oil and Mineral Oil.
Summary of the invention This invention relates to a therapeutic composition for the treatment of wounds and diseases that is comprised of natural ingredients.
From personal experience we have discovered the following traits associated with the specific components of the invention:
Vitamin A topically applied to the skin, particularly on the face, results in improved appearance of the skin;
Vitamin C acts like natural Aspiring by combating pain and inflammation. It is known to help arthritis;
Vitamin E topically applied to scalds results in reduced pain and improved healing of the wound;
Evenin;~ Primrose Oil topically applied to the face results in a healthier appearance of the skin. Used on wounds, i.e. after a gall bladder surgery, applied daily for six weeks, results in advanced healing of the wound. It may also be used to treat chronic fatigue syndrome;
Mineral Oil topically applied to severe sunburn may result in easement of pain and reduced inflammation of the wound;
Mynah has antiseptic and astringent properties that may reduce inflammation and infection, thereby promoting healing of healthy tissue;
Olive Oil aids in dry skin problems and helps to clean and heal wounds, ulcers, sores, abrasions, and sunburn; and, Peppermint Extract topically applied, particularly to the head, results in reduced pain in, for example, cases of headache, sinus and earache.
Using our knowledge of and experience with the above ingredients, we experimented with various quantities of all of the ingredients combined into one composition, with several slight variants for specific indications. We discovered that the ingredients work well together and complemented and enhanced the restorative and healing effects of each other when combined, particularly in the proportions disclosed in the formulae of the various embodiments of the invention.
The invention is comprised of four (4) main elements and may be used topically or internally:
(a) Vitamin A
(b) Vitamin E
(c) Evening Primrose Oil (d) Mineral Oil In addition to the elements listed above, small amounts of Vitamin C and other natural ingredients such as Olive Oil, Peppermint Extract and Myrrah may be present in some embodiments. Additionally, some embodiments may use a suitable Garner, such as Petroleum Jelly, for topical application. The amount of carrier used can be varied to regulate the consistency of the composition. In some indications a thicker composition is more desirable.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
The invention, in a first preferred embodiment, is a topical or oral composition comprised of the following ingredients in the :Following proportions by volumes:
Vitamin A 0.5 - 2.5 Vitamin E 35 - 45 Evening Primrose Oil 45 - 55 Mineral Oil 4.5 - 6.5 This embodiment of the invention is effective as a therapeutic agent for the treatment of bedsores, earache, headache, and ezcema of and around the eye when applied on or proximal to the affected areas.
Example : A test of the preferred embodiment of the invention was performed in February 2001 using the following composition of ingredients:
Vitamin A 0.5 ml Vitamin E 15 ml Evening Primrose 20 ml Oil Mineral Oil 2.0 ml The patient was suffering from severe bedsores. We topically applied the composition of the preferred embodiment of the invention to the patient's wounds daily with startling success. The attending physicians and care workers were also very impressed with the results. The patient admitted that th.e pain diminished instantly upon the application of the composition that is the preferred embodiment of this invention and after five days of daily use, the sores were not painful at all. The inflammation of the wound greatly diminished and the wound appeared to be healing from the inside to the outside, at a rate much more rapid than normally associated with such sores. We have also tried the invention on itches, scalds, cold sores, sore throats, and burns with similar results.
In a second and further embodiment, the present invention provides a topical composition comprised of the same proportions of ingredients as in the first embodiment above, but using Petroleum Jelly as a carrier.
We have used the second embodiment in the successful treatment of psoriasis, body itch, insect bites, burns and scalds, and dry skin on the hands and face when it was applied on or proximal to the affected areas.
In a third and further embodiment, the present invention provides a topical composition comprised of the following ingredients in the following proportions by volumes:
Vitamin A 0.5 - 2.0 Vitamin E 30 - 45 Evening Primrose 45 - 55 Oil Mineral Oil 4 6 -Olive Oil 4 6 -in a suitable as carrier, such Petroleum Jelly.
We have used the third embodiment in the successful treatment of psoriasis, body itch, insect bites, dry skin on the face and hands, burns and scalds by applying it on or proximal to the affected areas. In one example of the third embodiment used topically for such treatment the composition had the following ingredients:
Vitamin A 0.5 ml Vitamin E 15 ml Evening Primrose 20 ml Oil Mineral Oil 2.0 ml Olive Oil 2.0 rnl In a fourth and further embodiment, the present invention provides a topical composition comprised of the following ingredients in the following proportions by volumes:
Vitamin A 0.5 - 2 Vitamin C 2 3.5 -Vitamin E 30 - 40 Evening Primrose 45 - .SS
Oil Mineral Oil 3.5 - 6.5 Myrrah 0.5 - 1.5 Olive Oil 3.5 - 6.5 in a suitable carrier, such as Petroleum Jelly.
We have used the fourth embodiment in the successful treatment of some types of psoriasis and some types of ezcema by applying it on or proximal to the affected area. In one example of the fourth embodiment used topically for such treatment the composition had the following ingredients:
Vitamin A 0.5 ml Vitamin C 1.0 ml Vitamin E 15 rr~l Evening Primrose 20 ml Oil Mineral Oil 2.0 ml Myrrah 0.4 rnl Olive Oil 2.0 ml In a fifth and further embodiment, the present invention provides a topical or oral composition comprised of the following ingredients in the following proportions by volumes:
Vitamin A 0.5 - 2 Vitamin C 2 - 3.5 Vitamin E 30 - 40 Evening Primrose 45 - 55 Oil Mineral Oil 3.5 - 6.5 Myrrah 0.5 - 1.5 Olive Oil 3.5 - b.5 Peppermint Extract0.5 - 1.5 in a suitable carrier, such as Petroleum Jelly, for topical applications.
We have used the fifth embodiment in the successful treatment of headaches and migraine. In one example of the fifth embodiment used topically by applying it on or proximal to the affected areas fox such treatment, the composition had the following ingredients:
Vitamin A 0.5 ml Vitamin C 1.0 ml Vitamin E 15 ml Evening Primrose 20 ml Oil Mineral Oil 2.0 ml Myrrah 0.4 ml Olive Oil 2.0 ml Peppermint Extract0.4 rnl As demonstrated, the invention provides a new and effective therapeutic composition comprised of all natural ingredients, for the treatment of wounds, sores and diseases.
While the invention has been described in detail and with reference to specific embodiments thereof, it will be apparent to one skilled in the art that various changes and modifications can be made therein without departing from the spirit and scope thereof.
Claims
1. A topical compound comprising:
Vitamin A;
Vitamin E;
Evening Primrose Oil; and Mineral Oil.
Vitamin A;
Vitamin E;
Evening Primrose Oil; and Mineral Oil.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002392544A CA2392544A1 (en) | 2001-07-05 | 2002-07-04 | Natural therapeutic composition for the treatment of wounds and sores |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002352674A CA2352674A1 (en) | 2001-07-05 | 2001-07-05 | Natural therapeutic composition for the treatment of wounds and sores |
| CA2,352,674 | 2001-07-05 | ||
| CA002392544A CA2392544A1 (en) | 2001-07-05 | 2002-07-04 | Natural therapeutic composition for the treatment of wounds and sores |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2392544A1 true CA2392544A1 (en) | 2003-01-05 |
Family
ID=25682649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002392544A Abandoned CA2392544A1 (en) | 2001-07-05 | 2002-07-04 | Natural therapeutic composition for the treatment of wounds and sores |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2392544A1 (en) |
-
2002
- 2002-07-04 CA CA002392544A patent/CA2392544A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5266318A (en) | Skin therapeutic mixture containing cold-processsed aloe vera extract, with yellow sap and aloin removed | |
| US5374661A (en) | Composition and method for transdermal delivery of diclofenac | |
| US5853732A (en) | Pharmaceutical compositions containing kukui nut oil | |
| JP2002512971A (en) | Topical substance mixture containing olive oil and honey | |
| WO1996014085A1 (en) | External preparation for skin protection | |
| WO1999059580A1 (en) | Preventives/remedies for skin diseases | |
| CA2883348C (en) | Composition comprising dihydroquercetin, a-tocopherol and bisabolol | |
| KR20220044558A (en) | External preparation containing cannabidiol, preparation method of composition, and use thereof | |
| US4708873A (en) | Method of chemically debriding uncerated necrotic tissue | |
| US8409628B2 (en) | Methods and compositions for oxygenation of skin to treat skin disorders | |
| US6051244A (en) | Fructose diphosphate topical compositions | |
| KR20150047505A (en) | Composition for treating psoriasis | |
| JPH08245409A (en) | Skin preparation for external use and bathing agent | |
| US5565189A (en) | Wound cleanser method of use | |
| US20030072828A1 (en) | Natural therapeutic composition for the treatment of wounds and sores | |
| KR20010071319A (en) | Minoxidil Compositions for External Use | |
| WO1994005272A1 (en) | Skin treatment compositions containing dimethylsulphone and dimethylsulphoxide | |
| JP2954366B2 (en) | Combination preparation for topical treatment of inflammatory skin diseases, containing chloramphenicol, gentamicin and nystatin as active ingredients | |
| CA2428164A1 (en) | Method for the treatment of inflammation | |
| US20190247352A1 (en) | Wound healing composition | |
| CA2392544A1 (en) | Natural therapeutic composition for the treatment of wounds and sores | |
| Semkina | Ointments, gels, liniments, and creams containing phytopreparations (a review) | |
| WO2019175902A1 (en) | A topical preparation for various skin ailments | |
| US5576005A (en) | Effectiveness of wart removal by compositions including propolis | |
| JPH08208498A (en) | Dermal preparation composition for external use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued | ||
| FZDE | Discontinued |
Effective date: 20060704 |